Just Spit Into A Pot For New Coronavirus Test That Could Replace Throat Swab

The saliva test is being trialled on frontline workers in Southampton.
LOADINGERROR LOADING

Get the latest on coronavirus. Sign up to the Daily Brief for news, explainers, how-tos, opinion and more.

A new coronavirus “spit test”, which could become an alternative to the existing invasive – and sometimes painful – deep nasal and throat swab, is being piloted by the government.

The new test only requires the individual to spit into a sample pot to be tested for current Covid-19 infection, the Department of Health and Social Care (DHSC) said.

More than 14,000 people working in GP surgeries, universities and other frontline roles in Southampton have been recruited for the first phase of the trial, which will be launched this week.

Participants will be tested once a week for four weeks. They will receive test results within 48 hours and details of those who test positive shared with the NHS Test and Trace Programme.

Southampton City Council, the University of Southampton and the NHS are jointly leading the project, the DHSC said, with the help of other public services in Hampshire.

There have been fears that the existing swab test could be yielding a significant number of false negatives, potentially due to the difficulty in swabbing the sinuses and back of the throat.

Research from Bristol University and John Hopkins University has found up to 20% of swab tests return false negatives.

It also provokes coughing and spluttering, putting health workers – already working in close quarters with the patient – at even greater risk of the droplet-borne infection.

It is hoped the new tests will significantly boost existing testing capacity and accessibility.

Health secretary Matt Hancock said: “Saliva testing could potentially make it even easier for people to take coronavirus tests at home, without having to use swabs.

“This trial will also help us learn if routine, at-home testing could pick up cases of the virus earlier.”

The test was developed by biomedical firm Optigene, and the DHSC said it is also weighing up other non-swab, saliva-based tests from four other companies.

It said it is also working with a number of manufacturers ready to scale up production of the kits.

Professor Keith Godfrey, from the University of Southampton, said: “The health, social and economic impacts of lockdown cannot be underestimated.

“Through this initiative we believe we can contribute to safely restoring economic activity within the city and region during national relaxation measures, whilst enabling people to regain their lives, work and education.”

Close

What's Hot